BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Biotech Beach

  Singular Genomics to Present at Cowen’s 43rd Annual Health Care Conference

  Singular Genomics Systems, Inc. today announced plans to present at Cowen’s 43rd Annual Health Care Conference in Boston, Massachusetts.

  February 23, 2023

   · 

  1 min read
• Business

  Iridex to Report Fourth Quarter and Full Year 2022 Financial Results on March 9, 2023

  Iridex Corporation today announced the Company will release financial results for the fourth quarter and full year 2022 after the close of trading on Thursday, March 9, 2023.

  February 23, 2023

   · 

  1 min read
• Business

  Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results

  Vir Biotechnology, Inc. today provided a corporate update and reported financial results for the fourth quarter and full year ended December 31, 2022.

  February 23, 2023

   · 

  24 min read
• Business

  MannKind Corporation Reports 2022 Fourth Quarter and Full Year Financial Results

  MannKind Corporation (Nasdaq: MNKD) today reported financial results for the fourth quarter and full year ended December 31, 2022.

  February 23, 2023

   · 

  11 min read
• Pharm Country

  SELLAS Life Sciences Announces Proposed Underwritten Public Offering

  SELLAS Life Sciences Group, Inc. (Nasdaq: SLS) (“SELLAS” or the “Company”) today announced that it has commenced an underwritten public offering of shares of its common stock and warrants to purchase shares of its common stock.

  February 23, 2023

   · 

  4 min read
• Business

  LeMaitre Q4 2022 Financial Results

  LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q4 2022 results, announced a $0.14/share quarterly dividend (+12%) and provided guidance.

  February 23, 2023

   · 

  12 min read
• Genetown

  Akebia Receives Positive CHMP Opinion in Europe for Vafseo™ (vadadustat) for the Treatment of Symptomatic Anaemia Associated with Chronic Kidney Disease in Adults on Chronic Maintenance Dialysis

  Akebia Therapeutics , Inc. (NASDAQ: AKBA) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the European Commission (EC) to approve Vafseo.

  February 23, 2023

   · 

  5 min read
• Business

  Penumbra, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results

  Penumbra, Inc. today reported financial results for the fourth quarter and full year ended December 31, 2022.

  February 23, 2023

   · 

  19 min read
• Business

  Insulet Reports Full Year 2022 Revenue Increase of 19% (22% constant currency1) and Fourth Quarter 2022 Revenue Increase of 20% Year-Over-Year (23% constant currency)

  Insulet Corporation announced financial results for the three months and full year ended December 31, 2022.

  February 23, 2023

   · 

  17 min read
• Business

  Personalis Reports Fourth Quarter and Full Year 2022 Financial Results

  Personalis, Inc. today reported financial results for the fourth quarter and full year ended December 31, 2022, and provided recent business highlights.

  February 23, 2023

   · 

  10 min read